Differences in human immunodeficiency virus care and treatment among subpopulations in the United States

JAMA Internal Medicine

Volumn 173, Issue 14, 2013, Pages 1337-1344

  Hall, H Irene ^a   Frazier, Emma L ^a   Rhodes, Philip ^a   Holtgrave, David R ^b   Furlow Parmley, Carolyn ^a   Tang, Tian ^c   Gray, Kristen Mahle ^a   Cohen, Stacy M ^a   Mermin, Jonathan ^a   Skarbinski, Jacek ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c ICF INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CD4 ANTIGEN;

ADOLESCENT; ADULT; AGE; AGED; ANTIVIRAL THERAPY; ARTICLE; AWARENESS; DISEASE SURVEILLANCE; FEMALE; HEALTH CARE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; UNITED STATES; VIRUS LOAD; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGE FACTORS; ANTI-RETROVIRAL AGENTS; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CONTINENTAL POPULATION GROUPS; CONTINUITY OF PATIENT CARE; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HEALTHCARE DISPARITIES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; UNITED STATES; VIRAL LOAD; YOUNG ADULT;

EID: 84880661041     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.6841     Document Type: Article

References (31)

1. Centers for Disease Control and Prevention. Vital signs: HIV prevention through care and treatment-United States. MMWR Morb Mortal Wkly Rep. 2011;60(47):1618-1623.
2. Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data: United States and 6 US dependent areas-2010. HIV Surveillance Supplemental Report. 2012;17(3, part A). Published June 2012. http://www.cdc.gov/hiv/topics/surveillance/ resources/reports/. Accessed August 8, 2012.
3. Hall HI, Holtgrave DR, Maulsby C. HIV transmission rates from persons living with HIV who are aware and unaware of their infection. AIDS. 2012;26(7):893-896.
4. Giordano TP, Gifford AL, White AC Jr, et al. Retention in care: a challenge to survival with HIV infection. Clin Infect Dis. 2007;44(11):1493- 1499.
5. Mugavero MJ, Davila JA, Nevin CR, Giordano TP. From access to engagement: measuring retention in outpatient HIV clinical care. AIDS Patient Care STDS. 2010;24(10):607-613.
6. Mugavero MJ, Lin H-Y, Willig JH, et al.Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clin Infect Dis. 2009;48(2):248-256.
7. Ulett KB, Willig JH, Lin HY, et al. The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDS. 2009;23(1): 41-49.
8. Aberg JA, Kaplan JE, Libman H, et al; HIV Medicine Association of the Infectious Diseases Society of America. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(5): 651-681.
9. Prejean J, Song R, Hernandez A, et al; HIV Incidence Surveillance Group. Estimated HIV incidence in the United States, 2006-2009. PLoS One. 2011;6(8):e17502. doi:10.1371/journal.pone.0017502.
10. Centers for Disease Control and Prevention. Diagnoses of HIV infection and AIDS in the United States and dependent areas, 2010. HIV Surveillance Report, vol. 22. Atlanta, GA: US Dept of Health and Human Services, CDC; 2012. http://www.cdc.gov/hiv/surveillance/resources/reports/2010report/index.htm. Accessed May 25, 2012.
11. Hall HI, Song R, Rhodes P, et al; HIV Incidence Surveillance Group. Estimation of HIV incidence in the United States. JAMA. 2008;300(5):520-529.
12. McNaghten AD,Wolfe MI, Onorato I, et al. Improving the representativeness of behavioral and clinical surveillance for persons with HIV in the United States: the rationale for developing a population-based approach. PLoS One. 2007;2(6): e550. doi:10.1371/journal.pone.0000550.
13. Blair JM, McNaghten AD, Frazier EL, Skarbinski J, Huang P, Heffelfinger JD. Clinical and behavioral characteristics of adults receiving medical care for HIV infection: Medical Monitoring Project, United States, 2007. MMWR Surveill Summ. 2011;60(11): 1-20.
14. Frankel MR, McNaghten AD, Shapiro MF, et al. A probability sample for monitoring the HIV-infected population in care in the U.S. and in selected states. Open AIDS J. 2012;6:67-76. doi:10.2174/1874613601206010067.
15. Oehlert GW. A note on the delta method. Am Stat. 1992;46(1):27-29.
16. DeNavas-Walt C, Proctor BD, Smith JC. US Census Bureau, Current Population Reports, P60-243: Income, Poverty, and Health Insurance Coverage in the United States: 2011.Washington, DC: US Census Bureau; 2012.
17. Horstmann E, Brown J, Islam F, Buck J, Agins BD. Retaining HIV-infected patients in care: where are we? where do we go from here? Clin Infect Dis. 2010;50(5):752-761.
18. Wohl AR, Galvan FH, Myers HF, et al. Do social support, stress, disclosure and stigma influence retention in HIV care for Latino and African American men who have sex with men and women? AIDS Behav. 2011;15(6):1098-1110.
19. McNairy ML, El-Sadr WM. The HIV care continuum: no partial credit given. AIDS. 2012;26(14):1735-1738.
20. Centers for Disease Control and Prevention. Vital signs: HIV infection, testing, and risk behaviors among youth-United States. MMWR Morb Mortal Wkly Rep. 2012;61(47):971-976.
21. Rudy BJ, Murphy DA, Harris DR, Muenz L, Ellen J; Adolescent Trials Network for HIV/AIDS Interventions. Patient-related risks for nonadherence to antiretroviral therapy among HIV-infected youth in the United States: a study of prevalence and interactions. AIDS Patient Care STDS. 2009;23(3):185-194.
22. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Dept of Health and Human Services. January 10, 2011:1-166. http://www.aidsinfo. nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed April 8, 2011.
23. Thompson MA, Mugavero MJ, Amico KR, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med. 2012;156(11):817-833; W-284. doi:10.1059/0003-4819-156-11-201206050-00419.
24. Gardner LI,Metsch LR, Anderson-Mahoney P, et al; Antiretroviral Treatment and Access Study (ARTAS) Study Group. Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS. 2005;19(4):423-431.
25. Bradford JB. The promise of outreach for engaging and retaining out-of-care persons in HIV medical care. AIDS Patient Care STDS. 2007;21(suppl 1):S85-S91.
26. Wohl AR, Garland WH,Wu J, et al. A youth-focused case management intervention to engage and retain young gay men of color in HIV care. AIDS Care. 2011;23(8):988-997.
27. Thompson MA, Aberg JA, Hoy JF, et al. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA. 2012;308(4): 387-402.
28. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Dept of Health and Human Services. March 27, 2012:1-166. http://www.aidsinfo. nih.gov/contentfiles/lvguidelines/adultandadolescentgl .pdf. Accessed August 19, 2012.
29. Office of National AIDS Policy. National HIV/AIDS Strategy. July 2010. http://www.whitehouse.gov/administration/eop/onap/nhas/. Accessed November 6, 2012.
30. Hall HI, Gray KM, Tang T, Li J, Shouse L, Mermin J. Retention in care of adults and adolescents living with HIV in 13 US areas. J Acquir Immune Defic Syndr. 2012;60(1):77-82.
31. Thompson MA, Aberg JA, Cahn P, et al; International AIDS Society-USA. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA. 2010;304(3):321-333.